ARCHIVES

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

This article is from The Cancer Letter archive.

Vol. 05 No. 46 | November 16, 1979

Download PDF Visit The Full Archive

Related Articles

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001

NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group

February 3, 1995

NCI Advisory Group, Other Cancer Meetings

November 26, 1976

Eight Centers Picked To Host Regional Breast Cancer Summits

January 31, 1992

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

Survey Commissioned By Cancer Control Program Finds Important RMP Effort Being Phased Out

July 19, 1974